Healthcare Industry News: S.A.
News Release - April 3, 2013
Monteris Medical's AutoLITT- NeuroBlate System for Brain Tumors Receives Regulatory Approval in Canada
PLYMOUTH, Minn.--(Healthcare Sales & Marketing Network)--Monteris® Medical announced that Health Canada haS.A.proved the AutoLITT® (now known as NeuroBlate®) System, an MRI-guided ablation therapy for brain lesions, for commercialization in Canada. The NeuroBlate System has been available in the U.S.A. and prior to thiS.A.proval, in British Columbia, Canada, under a “special access waiver” granted for patients of Dr. Brian Toyota, M.D., in Vancouver.The NeuroBlate System provides focal ablation (lethal heat therapy) for tumorS.A.d has been commercially available in the United S.A.es since 2010. “We are excited that the NeuroBlate System will now be available for neurosurgeonS.A.d their patients in Canada,” S.A.ed John Schellhorn, President and CEO of Monteris. "ThiS.A.proval is especially gratifying given that the company was founded in Winnipeg, Manitoba and a significant portion of our people and operations remain in Canada. We are expanding our saleS.A.d marketing efforts to support Canadian neurosurgical centers offering brain tumor patients new therapieS.A.d technologies.”
Dr. Toyota added, "I am very enthused to have the first-in-Canada NeuroBlate System placed in Vancouver. It iS.A. exciting and innovative technology that representS.A.powerful treatment option. I am confident it will have a significant impact on the management of, and outcomes for, Canadians suffering from brain tumors."
About Monteris Medical
Formed in 1999, Monteris® Medical iS.A.privately held medical device company dedicated to the development of innovative MRI-guided, laser-based brain lesion therapy. Monteris® Medical markets the NeuroBlate® System, a neurosurgical ablation device providing controlled therapy for difficult-to-treat brain tumorS.A.d epilepsy. MonteriS.A.so offers the AXiiiS® Stereotactic Miniframe; a single use platform for image-guided, stereotactic brain biopsy; and the AtamA™ Head Coil and S.A.ilization System for MRI-guided neurosurgical procedures requiring head fixation. www.monteris.com
Source: Monteris Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!